Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1441 AL 1455

Telomerase in Brain: The New Kid on the Block and Its Role in Neurodegenerative Diseases

Saretzki G, Wan T.

Biomedicines. 2021 Apr 29;9(5):490. doi: 10.3390/biomedicines9050490.

Synaptic Zinc: An Emerging Player in Parkinson's Disease

Sikora J, Ouagazzal AM.

Int J Mol Sci. 2021 Apr 29;22(9):4724. doi: 10.3390/ijms22094724.

A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson's Disease and Parkinsonian Mice

Bogdanov V, Kim A, Nodel M, Pavlenko T, Pavlova E, Blokhin V, Chesnokova N, Ugrumov M.

Int J Mol Sci. 2021 Apr 29;22(9):4736. doi: 10.3390/ijms22094736.

Fibroblast Growth Factor 20 Gene Polymorphism in Parkinson's Disease in Asian Population: A Meta-Analysis

Chiang HL, Wu YR, Chen YC, Fung HC, Chen CM.

Genes (Basel). 2021 Apr 29;12(5):674. doi: 10.3390/genes12050674.

Is fatigue a muscular phenomenon in Parkinson's disease? Implications for rehabilitation

Fundarò C, Gazzoni M, Pinna GD, Dallocchio C, Rainoldi A, Casale R.

Eur J Phys Rehabil Med. 2021 Oct;57(5):691-700. doi: 10.23736/S1973-9087.21.06621-1. Epub 2021 May 5.

Close relationships in Parkinson´s disease patients with device-aided therapy

Scharfenort M, Timpka J, Sahlström T, Henriksen T, Nyholm D, Odin P.

Brain Behav. 2021 Jun;11(6):e02102. doi: 10.1002/brb3.2102. Epub 2021 May 5.

Effects of vitamin E on neurodegenerative diseases: an update

Icer MA, Arslan N, Gezmen-Karadag M.

Acta Neurobiol Exp (Wars). 2021;81(1):21-33. doi: 10.21307/ane-2021-003.

Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item-score models

Chen C, Jönsson S, Yang S, Plan EL, Karlsson MO.

CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):309-317. doi: 10.1002/psp4.12601.

Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia

Fabbrini A, Guerra A.

J Exp Pharmacol. 2021 Apr 29;13:469-485. doi: 10.2147/JEP.S265282. eCollection 2021.

Dopamine Receptors in Parkinson's Disease: A Meta-Analysis of Imaging Studies

Kaasinen V, Vahlberg T, Stoessl AJ, Strafella AP, Antonini A.

Mov Disord. 2021 Aug;36(8):1781-1791. doi: 10.1002/mds.28632. Epub 2021 May 6.

Catheter ablation of accessory pathways: Can we do better by using dual chamber mapping?

Calkins H.

J Cardiovasc Electrophysiol. 2021 Jul;32(7):1884-1885. doi: 10.1111/jce.15071. Epub 2021 May 16.

The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study

Sorbera C, Brigandì A, Cimino V, Bonanno L, Ciurleo R, Bramanti P, Di Lorenzo G, Marino S.

PLoS One. 2021 May 6;16(5):e0251313. doi: 10.1371/journal.pone.0251313. eCollection 2021.

Psychotherapy for the Treatment of Anxiety and Depression in Patients with Parkinson Disease: A Meta-Analysis of Randomized Controlled Trials

Hong CT, Tan S, Huang TW.

J Am Med Dir Assoc. 2021 Nov;22(11):2289-2295.e2. doi: 10.1016/j.jamda.2021.03.031. Epub 2021 May 3.

Comparison of pramipexole and levodopa/benserazide combination therapy versus levodopa/benserazide monotherapy in the treatment of Parkinson's disease: a systematic review and meta-analysis

Jiang DQ, Zang QM, Jiang LL, Wang Y, Li MX, Qiao JY.

Naunyn Schmiedebergs Arch Pharmacol. 2021 Sep;394(9):1893-1905. doi: 10.1007/s00210-021-02089-z. Epub 2021 May 7.

Effects on monotherapy and reduction of antipsychotic drugs by clozapine therapy in Japanese patients with treatment-resistant schizophrenia

Akamine Y, Kikuchi Y, Miura M.

J Clin Pharm Ther. 2021 Oct;46(5):1312-1318. doi: 10.1111/jcpt.13432. Epub 2021 May 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias